News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
A Look at Biogen (BIIB)'s Big Bet on the Holy Grail of Science—Alzheimer's     3/28/2017
Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos     3/28/2017
How This New Jersey Biotech is Taking on Amgen (AMGN)     3/27/2017
Bay Area's Ultragenyx (RARE) Tanks as Seizure Drug Flunks Phase II Test     3/24/2017
5 Biotechs That Have Major Catalysts Coming in the Next 6 to 9 Months     3/24/2017
Why Struggling Bristol-Myers Squibb (BMY) Could Take Out This Danish Biotech in Major €500M Deal     3/23/2017
Novartis AG (NVS)'s Phase III Drug for Heart Failure Bombs Trial     3/23/2017
How This Drug Candidate Could be a Winner in Gilead (GILD)'s Pipeline     3/23/2017
Heat Biologics (HTBX) Rockets as Lung Cancer Med Hits Mid-Stage Goals     3/22/2017
Novartis AG (NVS) Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year     3/3/2017
Kite Pharma (KITE)'s CAR-T Blood Cancer Candidate Succeeds in Major Study     3/2/2017
3 Biotechs With the Biggest and Most Promising Pipelines     2/20/2017
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt     2/20/2017
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study     2/16/2017
ArmaGen CEO: Phase II Data Shows Cognitive Improvement in Juvenile Hurler Syndrome Patients     2/16/2017

Featured Stories
Matinas BioPharma's Weak Drug Pipeline And Investors With Fraudulent Histories     3/27/2017
This Cheap Michigan Biotech Could Have Major Phase II Catalysts Coming     3/20/2017
Why Ionis Pharma (IONS)'s Extensive And Deep Pipeline Could Get Investors' Hearts Pumping     3/8/2017
An Expected Failure From Karyopharm (KPTI)'s Selinexor Doesn't Change The Bull Thesis     3/6/2017
Roche (RHHBY)'s Renal Success Spells Danger For All-Comer Studies     2/27/2017
Why 2017 Will be a Data-Rich and Not Revenue-Focused Year for bluebird bio (BLUE)     2/24/2017
Could Marijuana Be the Next Miracle Drug For Treating Cancer?     2/20/2017
Allergan (AGN) R&D Chief Reveals 6 Drugs That Could be Potential Blockbusters     2/14/2017
5 Daring Biopharmas Mixing Drugs With Marijuana     2/6/2017
Scientists Highlight the Hopes and Fears of Cellectis (ALCLS)' CAR-T     1/26/2017
Novartis AG (NVS) Shows Off 13 Potential Blockbusters in Pipeline     1/25/2017
3 Drugs Heading To The FDA Soon     12/12/2016
10 Drugs That Could be Johnson & Johnson (JNJ)'s New Blockbusters     11/2/2016
A Look at BioMarin (BMRN)'s Potential Blockbuster and the Science Behind It All     10/21/2016
4 Small Biotechs That Could Give Gilead (GILD), Merck & Co. (MRK) Pfizer (PFE) Some Competition With NASH     10/7/2016
Tiny SoCal Pharma Ritter Pharma Hails A Mid-Stage Victory After Changing The Primary Endpoint And Recalculating Data Of Lactose Intolerance Drug     3/29/2017
Positive Results Of Phase IIb Clinical Trial Of Pharmalink AB's Nefecon In Primary IgA Nephropathy Published In The Lancet     3/29/2017
Acorda (ACOR) Announces Long-Term Safety Data For CVT-301     3/29/2017
BAVENCIO (Avelumab) Approved For The Treatment Of Metastatic Merkel Cell Carcinoma, Available For Order At BioLogics     3/29/2017
Clementia Release: Phase II Part A Open Label Extension Trial Of Palovarotene For Treatment Of Patients With Fibrodysplasia Ossificans Progressiva Continues Positive Trends     3/28/2017
CureLab, Inc. Publishes Results Of Phase I/IIa Clinical Trials Of Its Anti-Cancer DNA Vaccine, Elenagen     3/28/2017
Replicel Life Sciences's Successful RCT-01 Tendon Repair Clinical Trial Shows Signs Of Healing Chronic Tendon Problems     3/28/2017
Akebia (AKBA) Announces Publication Of Phase IIa Results For Vadadustat In Patients With Anemia Related To Chronic Kidney Disease     3/28/2017
Oncoceutics Release: ONC201 Phase I Trial Results Reported In Clinical Cancer Research     3/28/2017
Lysogene Announces Baseline Data From First International Pivotal Observational Study In MPS IIIA     3/28/2017
Millendo Therapeutics Announces Initiation Of Phase II Clinical Trial Of ATR-101 In Patients With Endogenous Cushing’s Syndrome     3/28/2017
RXi Pharma (RXII) Granted Patent In Japan For Lead Clinical Candidate RXI-109     3/28/2017
Akervall Technologies Awarded Highly Competitive National Science Foundation Phase IIB SBIR Grant     3/28/2017
Infectex Announces Positive Phase IIb-III Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis     3/27/2017
Omeros (OMER) To Present Results From Dose-Ranging Stage Of OMS721 Clinical Trial In Atypical Hemolytic Uremic Syndrome At World Congress Of Nephrology     3/27/2017

More News
No News Posted on that date

Career Tips
How This Senior Scientist Got A Job At StemBioSys     3/28/2017
What 5 Different Pharma Marketing Careers Look Like     3/28/2017
5 Mistakes To Avoid When Talking To A Life Science Job Recruiter     3/28/2017
Things To Factor In When Deciding To Do A Postdoc In Academia Or Industry     3/28/2017
How To Get A Product Manager Gig In Biotech     3/25/2017
How To Rework Your Resume To Make The Big Data Leap From Tech To Biotech     3/23/2017
Scientists: 7 Ways How to Avoid Biotech Employers That Are Likely to Go Financially Bust     3/17/2017
True or False: Publishing Negative Results Ruins Your Science Career     3/16/2017
A Day In The Life Of A Scientist At AstraZeneca     3/16/2017
A New Career For Scientists: Science Communication     3/16/2017
In Between Jobs? Become A Lab Rat For Science     3/16/2017
Why These 3 Reasons Can Make You Stay Or Leave Your Life Science Job     3/16/2017
The Secret Lives Of Scientists     3/16/2017
Scientists, Here’s the Best Elevator Pitch to Sell Yourself to a Potential Employer     3/3/2017
This Technical Skill Wanted for Cancer Research Jobs     3/3/2017

Other News Sources
//-->